Nafpenzal 3D, suspensie voor intramammair gebruik voor runderen
  • Nafcillin
  • Dihidrostreptomicīns
  • Benzilpenicilīna prokaīna sāls
  • Valid
Authorised in these countries:
  • Netherlands
Export to PDF

Product identification

Medicine name:
Nafpenzal 3D, suspensie voor intramammair gebruik voor runderen
Active substance and strength:
  • Nafcillin
    100.00
    milligram(s)
    /
    1.00
    Dose
  • Dihidrostreptomicīns
    100.00
    milligram(s)
    /
    1.00
    Dose
  • Benzilpenicilīna prokaīna sāls
    300.00
    milligram(s)
    /
    1.00
    Dose
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC23
Authorisation number:
  • REG NL 9705
Product identification number:
  • d64bc050-61da-4460-b335-6c276de7da9e
Permanent identification number:
  • 600000059367

Product details

Legal status of supply:
This information is not available for this product.
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle

Availability

Package description:
Manufacturing sites for batch release:
  • Intervet International B.V.
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.

Authorisation details

Authorisation status:
  • Valid
Authorisation procedure type:
  • Marketing Authorisation
Procedure number:
This information is not available for this product.
Date of authorisation status change:
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Authorisation country:
  • Netherlands
Responsible authority:
  • Medicines Evaluation Board
Marketing authorisation holder:
  • Intervet Nederland B.V.
Marketing authorisation issued:
Reference member state:
This information is not available for this product.
Concerned member states:
This information is not available for this product.
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.

Additional information

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

Documents

Combined File of all Documents (PDF)
First published:
Last updated:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."